Last reviewed · How we verify
Tianshu capsule — Competitive Intelligence Brief
marketed
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Tianshu capsule (Tianshu capsule) — Jiangsu Kanion Pharmaceutical Co., Ltd. Tianshu capsule is a traditional Chinese medicine formulation that modulates immune function and promotes apoptosis in cancer cells through multiple herbal components.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tianshu capsule TARGET | Tianshu capsule | Jiangsu Kanion Pharmaceutical Co., Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tianshu capsule CI watch — RSS
- Tianshu capsule CI watch — Atom
- Tianshu capsule CI watch — JSON
- Tianshu capsule alone — RSS
Cite this brief
Drug Landscape (2026). Tianshu capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/tianshu-capsule. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing